Lipodystrophic Laminopathies: From Dunnigan Disease to Progeroid Syndromes
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179324 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Everardo Josué Díaz-López und 6 weiteren Autor:innen. Beteiligte Einrichtung: UETeM-Molecular Pathology Group, Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, IDIS-CIMUS, University of Santiago de Comp…. Hauptthemen laut MEDLINE: Progeria, Lamin Type A, Lipodystrophy, Laminopathies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Union, Xunta de Galicia.
Abstract (Originalsprache)
Lipodystrophic laminopathies are a group of ultra-rare disorders characterised by the presence of pathogenic variants in the same gene (LMNA) and other related genes, along with an impaired adipose tissue pattern and other features that are specific of each of these disorders. The most fascinating traits include their complex genotype-phenotype associations and clinical heterogeneity, ranging from Dunnigan disease, in which the most relevant feature is precisely adipose tissue dysfunction and lipodystrophy, to the other laminopathies affecting adipose tissue, which are also characterised by the presence of signs of premature ageing (Hutchinson Gilford-progeria syndrome, LMNA-atypical progeroid syndrome, mandibuloacral dysplasia types A and B, Nestor-Guillermo progeria syndrome, LMNA-associated cardiocutaneous progeria). This raises several questions when it comes to understanding how variants in the same gene can lead to similar adipose tissue disturbances and, at the same time, to such heterogeneous phenotypes and variable degrees of metabolic abnormalities. The present review aims to gather the molecular basis of adipose tissue impairment in lipodystrophic laminopathies, their main clinical aspects and recent therapeutic strategies. In addition, it also summarises the key aspects for their differential diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UETeM-Molecular Pathology Group, Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, IDIS-CIMUS, University of Santiago de Compostela, 15706 Santiago de Compostela, Spain.
- Division of Endocrinology and Nutrition, University Clinical Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain.
- CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 28029 Madrid, Spain.
ORCID-Profile: Everardo Josué Díaz-López, Sofía Sánchez-Iglesias, Silvia Cobelo-Gómez, David Araújo-Vilar, Antia Fernandez-Pombo
Förderung
- Instituto de Salud Carlos III
- European Union
- Xunta de Galicia
- ERDF
- Asociación Española de Familiares y Afectados de Lipodistrofias (AELIP)
Zitieren
APA
Díaz-López, E. J., Sánchez-Iglesias, S., Castro, A. I., Cobelo-Gómez, S., Prado-Moraña, T., Araújo-Vilar, D., & Fernandez-Pombo, A. (2024). Lipodystrophic Laminopathies: From Dunnigan Disease to Progeroid Syndromes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179324
Vancouver
Díaz-López EJ, Sánchez-Iglesias S, Castro AI, Cobelo-Gómez S, Prado-Moraña T, Araújo-Vilar D, et al. Lipodystrophic Laminopathies: From Dunnigan Disease to Progeroid Syndromes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179324
BibTeX
@article{DazLpez2024,
author = {Díaz-López, Everardo Josué and Sánchez-Iglesias, Sofía and Castro, Ana I and Cobelo-Gómez, Silvia and Prado-Moraña, Teresa and Araújo-Vilar, David and Fernandez-Pombo, Antia},
title = {Lipodystrophic Laminopathies: From Dunnigan Disease to Progeroid Syndromes},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179324}
}
EUVIMED